Skip to main content
Clinical Trials/NCT03090399
NCT03090399
Completed
Not Applicable

Effects of the Goal-directed Fluid Therapy on ASA 1 Patients Scheduled for Intensive Debulking Surgery

ConditionsHemodynamics

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hemodynamics
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Enrollment
60
Primary Endpoint
prevalence of complications
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

In this retrospective analysis investigators will study the effects of using a minimally invasive hemodynamic monitoring (FloTrac-Edwards) on postoperative outcomes. Participants will compare a control group to a case group; in both groups ASA 1 patients suffering from advanced ovarian cancer underwent radical cytoreductive surgery. In case group hemodynamic was managed by using the FloTrac system; in the control group a standard hemodynamic monitoring was used.

Registry
clinicaltrials.gov
Start Date
January 2012
End Date
January 2017
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr.Andrea Russo

Medical Doctor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • cardiac diseases
  • pulmonary diseases
  • renal diseases
  • metabolic disorders

Outcomes

Primary Outcomes

prevalence of complications

Time Frame: up to 30 days

Secondary Outcomes

  • days of hospitalization(up to 12 weeks)

Similar Trials